SFL Regulatory Affairs & Scientific Communication GmbH

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 15 Apr 2020
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

250,000€

Financial year: Jan 2019 - Dec 2019

Lobbyists (Full time equivalent)

1.5 Fte (4)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    SFL Regulatory Affairs & Scientific Communication GmbH   (SFL)

    EU Transparency Register

    31442479070-19 First registered on 02 Jul 2012

    Goals / Remit

    SFL Regulatory Affairs & Scientific Communication GmbH (SFL) is a leading consultancy company providing integrated solutions to the pharma and medtech sectors, from the bench to the marketplace, within one consultancy.

    SFL’s core competencies are:
    - Regulatory Affairs
    - Medical Affairs
    - Public Affairs
    - Quality Assurance
    - Clinical Safety & Pharmacovigilance
    - Supply Chain & Market Access
    - Legal & Compliance
    - Reimbursement and Training

    This enables SFL to understand and meet clients’ needs through every stage of the product lifecycle. Each team member has a proven track record in specific areas of expertise and an excellent understanding of the interconnectedness of the different stages and functions of the lifecycle of a product.

    SFL Public Affairs Services:
    The SFL Public Affairs team has longstanding experience in supporting clients to anticipate and analyze changes in EU healthcare policy and regulatory environment, to conduct stakeholder mapping and to plan and adapt engagement strategies with stakeholders relevant for their portfolios and corporate positions. Our high-quality global intelligence, materials and strategic advice is tailored to our clients’ specific needs. We do provide association management and communicate the members’ views with key stakeholders.

    SFL acts as secretariat of the associations Medtech & Pharma Platform (MPP) and Rare Disease Action Forum (RDAF), communicating members interests to key decision makers and organizing regular events and stakeholder meetings.

    Main EU files targeted

    - Implementation of Medical Devices Regulation and In-vitro Diagnostics Regulation
    - Orphan Medicinal Products Regulation, Pediatric Regulation
    - Incentives on medicinal products
    - Europe’s Beating Cancer Plan
    - Clinical Trials Regulation
    - General Data Protection Regulation
    - European Data Strategy, Artificial Intelligence and Cybersecurity
    - European Green Deal
    - Cross-border healthcare
    - Proposal for Regulation on Health Technology Assessment
    - EUnetHTA
    - European Medicines Agency policy on publication of
    clinical data for medicinal products for human use
    - Blood, tissues & cells legislation
    - Horizon Europe
    - EU pharmacovigilance system
    - EU personalized medicine activities such as use of '-omics' technologies in the development of personalized medicine
    - Access to Medicines
    - Shortages of medicinal products

    Address

    Head Office
    Schillerstrasse 7
    Basel 4053
    SWITZERLAND
  • People

    Total lobbyists declared

    4

    Employment timeLobbyists
    50%2
    25%2

    Lobbyists (Full time equivalent)

    1.5

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    I - Professional consultancies/law firms/self-employed consultants

    Subcategory

    Professional consultancies

  • Networking

    Affiliation

    SFL is a member of Medtech & Pharma Platform (MPP).

    SFL is a member of SWISS MEDTECH.

    SFL is a member of the British-Swiss Chamber of Commerce.

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2019 - Dec 2019

    Lobbying costs for closed financial year

    250,000€

    Other financial info

    None declared

    Declared lobby clients

    Client Name Amount
    F. Hoffmann-La Roche Ltd 100,000€ - 199,999€
    Medtech & Pharma Platform (MPP) 25,000€ - 49,999€
  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    None

    Communication activities

    SFL supports its clients with impact analysis and strategic communication advice on the dossiers and activities listed under ‘Main EU initiatives, policies and legislative files monitored by your organisation’. SFL advises on internal organizational matters to help clients formulate aligned positions and speak with one voice to regulators and policy-makers.

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard